May, 2024
May 2024
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Bishal Gyawali: The totality of evidence remains against routine adoption of adjuvant cdk4/6 as the default SOC
Mar 22, 2024, 23:26

Bishal Gyawali: The totality of evidence remains against routine adoption of adjuvant cdk4/6 as the default SOC

Bishal Gyawali, Associate Professor and Medical Oncologist at 

“This is a really good summary. Plus informative censoring and other adjuvant Cdk 4/6 trials with equally dubious results. The totality of evidence remains against routine adoption of adjuvant cdk4/6 as the default SOC. We discussed this in detail in our The Lancet Oncology essay, which still remains valid.”

Quoting Mark Bolton’s post:

“NATALEE: A good example of clinically insignificant ~3% benefit in a contrived endpoint at 3-years that jacks up toxicity, plus what happens at ~40 months? Hard to tell without CIs.”

Source: Bishal Gyawali/X and Mark Bolton/X